Call us for quotes at (610) 458-1112 or 
Email us at primbiobiz@primbioresearch.com
PrimBio
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Ion GeneStudio™ S5 Prime System
    • Ion PGM™ Sequencer
    • Ion Proton™ Sequencer
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Cancer Hotspot Panel
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • PrimBio MSI Cancer Panel
    • COVID-19 RT-PCR TEST
    • OSCC TEST
  • Get a Quote
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Ion GeneStudio™ S5 Prime System
    • Ion PGM™ Sequencer
    • Ion Proton™ Sequencer
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Cancer Hotspot Panel
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • PrimBio MSI Cancer Panel
    • COVID-19 RT-PCR TEST
    • OSCC TEST
  • Get a Quote

SaliMark™ OSCC:
Oral Cancer Salivary Diagnostic Test


Picture
SaliMark™ OSCC: Oral Cancer Salivary Diagnostic Test
A risk stratification test recommended for use by the clinician when suspicious lesions are observed and additional testing is warranted. These discriminatory salivary biomarkers have been clinically-validated in multiple large trials including studies in collaboration with the National Cancer Institute and with premiere US academic medical centers such as the University of Michigan, Michigan State University and the Providence Health System in Detroit.
MOLECULAR DIAGNOSTIC REQUISITION FORM

For more information about the SaliMark™ OSCC Test ​please visit the PeriRx website.
© COPYRIGHT 2016. ALL RIGHTS RESERVED.